IDNA — IDNA Genomics Public Cashflow Statement
0.000.00%
Last trade - 00:00- €27.65m
- €28.80m
- €0.49m
Annual cashflow statement for IDNA Genomics Public, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 7 W | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.25 | -0.365 | -1.34 | -2.97 | -3.44 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.046 | 0.095 | 0.045 | 1.48 | 1.29 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.479 | 1.05 | 1.05 | -1.32 | 1.58 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.143 | 0.922 | -0.011 | -2.52 | -0.246 |
| Capital Expenditures | -0.16 | -0.146 | -0.716 | -0.176 | -0.004 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.048 | — | — | 2 | 0 |
| Sale of Business | |||||
| Cash from Investing Activities | -0.112 | -0.146 | -0.716 | 1.82 | -0.004 |
| Financing Cash Flow Items | — | -0.095 | -0.131 | -0.145 | -0.196 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.214 | -0.801 | 0.682 | -0.265 | -0.094 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.041 | -0.024 | -0.045 | -0.96 | -0.344 |